Alimera Sciences Inc (NQ: ALIM )
8.530
USD
+0.100
(+1.19%)
Streaming Delayed Price
Updated: 3:19 PM EST, Feb 24, 2021
Add to My Watchlist
All news about Alimera Sciences Inc
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Today 7:30 EST
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
January 22, 2021
From Benzinga
From Benzinga
54 Biggest Movers From Friday
January 19, 2021
From Benzinga
82 Biggest Movers From Friday
January 11, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 07, 2021
From Benzinga
52 Stocks Moving In Monday's Mid-Day Session
December 14, 2020
From Benzinga
Alimera Sciences Announces Launch of ILUVIEN® in the Netherlands
December 09, 2020
Alimera Sciences Announces Third Quarter 2020 Financial Results
October 28, 2020
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
October 28, 2020
From Benzinga
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
October 25, 2020
From Benzinga
From InvestorBrandNetwork
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.